Bernstein maintains Coupang at Underperform, lowers price target to $11 from $12

Bernstein downgraded Coupang to Underperform, reducing its price target to $11 from $12, citing an 8.3% decrease. This implies a 35.5% downside from the Nov 4 close of $17.05.

Original reporting
Published Nov 5, 2026, 5:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 5:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Bernstein maintains Coupang at Underperform, lowers price target to $11 from $12 — source image
Decision brief

The 30-second read

$CPNGBearishMed
01

Why it matters

The downgrade lowers expectations and could trigger sell orders, especially in algorithmic models that track analyst target changes.

02

Market read

Analyst target cuts are a common catalyst for short‑term price moves; traders may adjust positions accordingly.

03

What to watch

Recent operational improvements and expanding logistics network may offset the target cut.

Relevance 6/10Novelty 5/10Timing: after-hours reaction

Background

Bernstein's rating change is the first public downgrade for Coupang in this reporting period.

Company-level read

Ticker impact

$CPNGBearishHigh confidence
Context

Bernstein lowered its price target for Coupang to $11 from $12, indicating a fresh downgrade.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

The new target implies a 35.5% downside from the recent close, prompting short‑term sell interest.

Market effects

Potential drag on e‑commerce and Asian tech exposure.

May weigh on broader Korean‑focused ETFs.

Limited to investors tracking emerging‑market e‑commerce stocks.

Counterpoint

If the downgrade is overly pessimistic, the stock could rebound on a short‑cover rally.

Key entities

  • Coupang

    South Korean e‑commerce platform listed on NASDAQ (CPNG).

  • Bernstein

    Equity research firm issuing the Underperform rating.

Related articles

$CPNGMedAI 8/10

What Is Behind The Move In Coupang Stock?

Coupang (CPNG) stock rose 12.0% on November 4, 2026, after reporting Q3 results. Revenue of $9.96B beat estimates, growing 7.5% YoY. EPS loss of $0.28 included $248M in fire-related costs. Management expects adjusted EBITDA margins to recover by mid-2027. The stock is down 46.9% over the past year.

$CPNGHighAI 8/10

Coupang Stock Edges Up Despite Wider-Than-Expected Loss

Coupang (CPNG) reported Q3 revenue of $9.96B, up 7% YoY, beating estimates. Loss of $0.28 per share was wider than expected due to a fire. Product Commerce revenue grew 5%, while Developing Offerings rose 23%. Margins declined, with adjusted EBITDA falling 72%. Q4 guidance expects 13-14% revenue growth and improved margins. Full-year Developing Offerings loss forecast raised by $50M-$100M.

$CPNGMed

Mizuho cuts Coupang stock price target on margin recovery concerns

Mizuho reduced its price target for Coupang (NYSE:CPNG) to $21 from $22, citing concerns over margin recovery and higher Taiwan investment. The firm lowered its fiscal 2027 EBITDA estimate but kept the 2028 estimate unchanged. Coupang reported $35.5 billion in revenue over the last twelve months, with 10% growth, but remains unprofitable with a negative EPS of $0.43. The stock has fallen 53% over the past year to $15.23, with analysts' price targets ranging from $12 to $30.